Adult Survivors of Child Adverse Events

The midurethral sling was associated with significantly higher rates of bladder perforation (6.7% vs 0%), urinary tract infection (31.0% vs 18.3%), major bleeding complications (3.1% vs 0%), and incom

Effect: adverse; Bladder perforation 6.7% vs 0%; UTI 31.0% vs 18.3%; major bleeding 3.1% vs 0%; incomplete emptying 3.7% vs 0%

The midurethral sling was associated with significantly higher rates of bladder perforation (6.7% vs 0%), urinary tract infection (31.0% vs 18.3%), major bleeding complications (3.1% vs 0%), and incom

Effect: adverse; Bladder perforation 6.7% vs 0%; UTI 31.0% vs 18.3%; major bleeding 3.1% vs 0%; incomplete emptying 3.7% vs 0%

The midurethral sling was associated with significantly higher rates of bladder perforation (6.7% vs 0%), urinary tract infection (31.0% vs 18.3%), major bleeding complications (3.1% vs 0%), and incom

Effect: adverse; Bladder perforation 6.7% vs 0%; UTI 31.0% vs 18.3%; major bleeding 3.1% vs 0%; incomplete emptying 3.7% vs 0%

The midurethral sling was associated with significantly higher rates of bladder perforation (6.7% vs 0%), urinary tract infection (31.0% vs 18.3%), major bleeding complications (3.1% vs 0%), and incom

Effect: adverse; Bladder perforation 6.7% vs 0%; UTI 31.0% vs 18.3%; major bleeding 3.1% vs 0%; incomplete emptying 3.7% vs 0%

The midurethral sling was associated with significantly higher rates of bladder perforation (6.7% vs 0%), urinary tract infection (31.0% vs 18.3%), major bleeding complications (3.1% vs 0%), and incom

Effect: adverse; Bladder perforation 6.7% vs 0%; UTI 31.0% vs 18.3%; major bleeding 3.1% vs 0%; incomplete emptying 3.7% vs 0%

The midurethral sling was associated with significantly higher rates of bladder perforation (6.7% vs 0%), urinary tract infection (31.0% vs 18.3%), major bleeding complications (3.1% vs 0%), and incom

Effect: adverse; Bladder perforation 6.7% vs 0%; UTI 31.0% vs 18.3%; major bleeding 3.1% vs 0%; incomplete emptying 3.7% vs 0%

The midurethral sling was associated with significantly higher rates of bladder perforation (6.7% vs 0%), urinary tract infection (31.0% vs 18.3%), major bleeding complications (3.1% vs 0%), and incom

Effect: adverse; Bladder perforation 6.7% vs 0%; UTI 31.0% vs 18.3%; major bleeding 3.1% vs 0%; incomplete emptying 3.7% vs 0%

The midurethral sling was associated with significantly higher rates of bladder perforation (6.7% vs 0%), urinary tract infection (31.0% vs 18.3%), major bleeding complications (3.1% vs 0%), and incom

Effect: adverse; Bladder perforation 6.7% vs 0%; UTI 31.0% vs 18.3%; major bleeding 3.1% vs 0%; incomplete emptying 3.7% vs 0%

The midurethral sling was associated with significantly higher rates of bladder perforation (6.7% vs 0%), urinary tract infection (31.0% vs 18.3%), major bleeding complications (3.1% vs 0%), and incom

Effect: adverse; Bladder perforation 6.7% vs 0%; UTI 31.0% vs 18.3%; major bleeding 3.1% vs 0%; incomplete emptying 3.7% vs 0%

The midurethral sling was associated with significantly higher rates of bladder perforation (6.7% vs 0%), urinary tract infection (31.0% vs 18.3%), major bleeding complications (3.1% vs 0%), and incom

Effect: adverse; Bladder perforation 6.7% vs 0%; UTI 31.0% vs 18.3%; major bleeding 3.1% vs 0%; incomplete emptying 3.7% vs 0%

The midurethral sling was associated with significantly higher rates of bladder perforation (6.7% vs 0%), urinary tract infection (31.0% vs 18.3%), major bleeding complications (3.1% vs 0%), and incom

Effect: adverse; Bladder perforation 6.7% vs 0%; UTI 31.0% vs 18.3%; major bleeding 3.1% vs 0%; incomplete emptying 3.7% vs 0%

The midurethral sling was associated with significantly higher rates of bladder perforation (6.7% vs 0%), urinary tract infection (31.0% vs 18.3%), major bleeding complications (3.1% vs 0%), and incom

Effect: adverse; Bladder perforation 6.7% vs 0%; UTI 31.0% vs 18.3%; major bleeding 3.1% vs 0%; incomplete emptying 3.7% vs 0%

The midurethral sling was associated with significantly higher rates of bladder perforation (6.7% vs 0%), urinary tract infection (31.0% vs 18.3%), major bleeding complications (3.1% vs 0%), and incom

Effect: adverse; Bladder perforation 6.7% vs 0%; UTI 31.0% vs 18.3%; major bleeding 3.1% vs 0%; incomplete emptying 3.7% vs 0%

The midurethral sling was associated with significantly higher rates of bladder perforation (6.7% vs 0%), urinary tract infection (31.0% vs 18.3%), major bleeding complications (3.1% vs 0%), and incom

Effect: adverse; Bladder perforation 6.7% vs 0%; UTI 31.0% vs 18.3%; major bleeding 3.1% vs 0%; incomplete emptying 3.7% vs 0%

The midurethral sling was associated with significantly higher rates of bladder perforation (6.7% vs 0%), urinary tract infection (31.0% vs 18.3%), major bleeding complications (3.1% vs 0%), and incom

Effect: adverse; Bladder perforation 6.7% vs 0%; UTI 31.0% vs 18.3%; major bleeding 3.1% vs 0%; incomplete emptying 3.7% vs 0%

The midurethral sling was associated with significantly higher rates of bladder perforation (6.7% vs 0%), urinary tract infection (31.0% vs 18.3%), major bleeding complications (3.1% vs 0%), and incom

Effect: adverse; Bladder perforation 6.7% vs 0%; UTI 31.0% vs 18.3%; major bleeding 3.1% vs 0%; incomplete emptying 3.7% vs 0%

The midurethral sling was associated with significantly higher rates of bladder perforation (6.7% vs 0%), urinary tract infection (31.0% vs 18.3%), major bleeding complications (3.1% vs 0%), and incom

Effect: adverse; Bladder perforation 6.7% vs 0%; UTI 31.0% vs 18.3%; major bleeding 3.1% vs 0%; incomplete emptying 3.7% vs 0%

The midurethral sling was associated with significantly higher rates of bladder perforation (6.7% vs 0%), urinary tract infection (31.0% vs 18.3%), major bleeding complications (3.1% vs 0%), and incom

Effect: adverse; Bladder perforation 6.7% vs 0%; UTI 31.0% vs 18.3%; major bleeding 3.1% vs 0%; incomplete emptying 3.7% vs 0%

The midurethral sling was associated with significantly higher rates of bladder perforation (6.7% vs 0%), urinary tract infection (31.0% vs 18.3%), major bleeding complications (3.1% vs 0%), and incom

Effect: adverse; Bladder perforation 6.7% vs 0%; UTI 31.0% vs 18.3%; major bleeding 3.1% vs 0%; incomplete emptying 3.7% vs 0%

The midurethral sling was associated with significantly higher rates of bladder perforation (6.7% vs 0%), urinary tract infection (31.0% vs 18.3%), major bleeding complications (3.1% vs 0%), and incom

Effect: adverse; Bladder perforation 6.7% vs 0%; UTI 31.0% vs 18.3%; major bleeding 3.1% vs 0%; incomplete emptying 3.7% vs 0%

The midurethral sling was associated with significantly higher rates of bladder perforation (6.7% vs 0%), urinary tract infection (31.0% vs 18.3%), major bleeding complications (3.1% vs 0%), and incom

Effect: adverse; Bladder perforation 6.7% vs 0%; UTI 31.0% vs 18.3%; major bleeding 3.1% vs 0%; incomplete emptying 3.7% vs 0%

The midurethral sling was associated with significantly higher rates of bladder perforation (6.7% vs 0%), urinary tract infection (31.0% vs 18.3%), major bleeding complications (3.1% vs 0%), and incom

Effect: adverse; Bladder perforation 6.7% vs 0%; UTI 31.0% vs 18.3%; major bleeding 3.1% vs 0%; incomplete emptying 3.7% vs 0%

The midurethral sling was associated with significantly higher rates of bladder perforation (6.7% vs 0%), urinary tract infection (31.0% vs 18.3%), major bleeding complications (3.1% vs 0%), and incom

Effect: adverse; Bladder perforation 6.7% vs 0%; UTI 31.0% vs 18.3%; major bleeding 3.1% vs 0%; incomplete emptying 3.7% vs 0%

The midurethral sling was associated with significantly higher rates of bladder perforation (6.7% vs 0%), urinary tract infection (31.0% vs 18.3%), major bleeding complications (3.1% vs 0%), and incom

Effect: adverse; Bladder perforation 6.7% vs 0%; UTI 31.0% vs 18.3%; major bleeding 3.1% vs 0%; incomplete emptying 3.7% vs 0%

The midurethral sling was associated with significantly higher rates of bladder perforation (6.7% vs 0%), urinary tract infection (31.0% vs 18.3%), major bleeding complications (3.1% vs 0%), and incom

Effect: adverse; Bladder perforation 6.7% vs 0%; UTI 31.0% vs 18.3%; major bleeding 3.1% vs 0%; incomplete emptying 3.7% vs 0%

The midurethral sling was associated with significantly higher rates of bladder perforation (6.7% vs 0%), urinary tract infection (31.0% vs 18.3%), major bleeding complications (3.1% vs 0%), and incom

Effect: adverse; Bladder perforation 6.7% vs 0%; UTI 31.0% vs 18.3%; major bleeding 3.1% vs 0%; incomplete emptying 3.7% vs 0%

The midurethral sling was associated with significantly higher rates of bladder perforation (6.7% vs 0%), urinary tract infection (31.0% vs 18.3%), major bleeding complications (3.1% vs 0%), and incom

Effect: adverse; Bladder perforation 6.7% vs 0%; UTI 31.0% vs 18.3%; major bleeding 3.1% vs 0%; incomplete emptying 3.7% vs 0%

Metformin caused significantly more diarrhea and headaches compared to placebo, with 6 dropouts in the metformin arm due to medication side effects versus none in placebo, though metformin users had f

Effect: adverse; 6 MET dropouts for medication side effects vs 0 PBO

Metformin caused significantly more diarrhea and headaches compared to placebo, with 6 dropouts in the metformin arm due to medication side effects versus none in placebo, though metformin users had f

Effect: adverse; 6 MET dropouts for medication side effects vs 0 PBO

Metformin caused significantly more diarrhea and headaches compared to placebo, with 6 dropouts in the metformin arm due to medication side effects versus none in placebo, though metformin users had f

Effect: adverse; 6 MET dropouts for medication side effects vs 0 PBO

Metformin caused significantly more diarrhea and headaches compared to placebo, with 6 dropouts in the metformin arm due to medication side effects versus none in placebo, though metformin users had f

Effect: adverse; 6 MET dropouts for medication side effects vs 0 PBO

Metformin caused significantly more diarrhea and headaches compared to placebo, with 6 dropouts in the metformin arm due to medication side effects versus none in placebo, though metformin users had f

Effect: adverse; 6 MET dropouts for medication side effects vs 0 PBO

Metformin caused significantly more diarrhea and headaches compared to placebo, with 6 dropouts in the metformin arm due to medication side effects versus none in placebo, though metformin users had f

Effect: adverse; 6 MET dropouts for medication side effects vs 0 PBO

Metformin caused significantly more diarrhea and headaches compared to placebo, with 6 dropouts in the metformin arm due to medication side effects versus none in placebo, though metformin users had f

Effect: adverse; 6 MET dropouts for medication side effects vs 0 PBO

Metformin caused significantly more diarrhea and headaches compared to placebo, with 6 dropouts in the metformin arm due to medication side effects versus none in placebo, though metformin users had f

Effect: adverse; 6 MET dropouts for medication side effects vs 0 PBO

Metformin caused significantly more diarrhea and headaches compared to placebo, with 6 dropouts in the metformin arm due to medication side effects versus none in placebo, though metformin users had f

Effect: adverse; 6 MET dropouts for medication side effects vs 0 PBO

Metformin caused significantly more diarrhea and headaches compared to placebo, with 6 dropouts in the metformin arm due to medication side effects versus none in placebo, though metformin users had f

Effect: adverse; 6 MET dropouts for medication side effects vs 0 PBO

Metformin caused significantly more diarrhea and headaches compared to placebo, with 6 dropouts in the metformin arm due to medication side effects versus none in placebo, though metformin users had f

Effect: adverse; 6 MET dropouts for medication side effects vs 0 PBO

Metformin caused significantly more diarrhea and headaches compared to placebo, with 6 dropouts in the metformin arm due to medication side effects versus none in placebo, though metformin users had f

Effect: adverse; 6 MET dropouts for medication side effects vs 0 PBO

Metformin caused significantly more diarrhea and headaches compared to placebo, with 6 dropouts in the metformin arm due to medication side effects versus none in placebo, though metformin users had f

Effect: adverse; 6 MET dropouts for medication side effects vs 0 PBO

Metformin caused significantly more diarrhea and headaches compared to placebo, with 6 dropouts in the metformin arm due to medication side effects versus none in placebo, though metformin users had f

Effect: adverse; 6 MET dropouts for medication side effects vs 0 PBO

Metformin caused significantly more diarrhea and headaches compared to placebo, with 6 dropouts in the metformin arm due to medication side effects versus none in placebo, though metformin users had f

Effect: adverse; 6 MET dropouts for medication side effects vs 0 PBO

Metformin caused significantly more diarrhea and headaches compared to placebo, with 6 dropouts in the metformin arm due to medication side effects versus none in placebo, though metformin users had f

Effect: adverse; 6 MET dropouts for medication side effects vs 0 PBO

Metformin caused significantly more diarrhea and headaches compared to placebo, with 6 dropouts in the metformin arm due to medication side effects versus none in placebo, though metformin users had f

Effect: adverse; 6 MET dropouts for medication side effects vs 0 PBO

Metformin caused significantly more diarrhea and headaches compared to placebo, with 6 dropouts in the metformin arm due to medication side effects versus none in placebo, though metformin users had f

Effect: adverse; 6 MET dropouts for medication side effects vs 0 PBO

Metformin caused significantly more diarrhea and headaches compared to placebo, with 6 dropouts in the metformin arm due to medication side effects versus none in placebo, though metformin users had f

Effect: adverse; 6 MET dropouts for medication side effects vs 0 PBO

Metformin caused significantly more diarrhea and headaches compared to placebo, with 6 dropouts in the metformin arm due to medication side effects versus none in placebo, though metformin users had f

Effect: adverse; 6 MET dropouts for medication side effects vs 0 PBO

Metformin caused significantly more diarrhea and headaches compared to placebo, with 6 dropouts in the metformin arm due to medication side effects versus none in placebo, though metformin users had f

Effect: adverse; 6 MET dropouts for medication side effects vs 0 PBO

Metformin caused significantly more diarrhea and headaches compared to placebo, with 6 dropouts in the metformin arm due to medication side effects versus none in placebo, though metformin users had f

Effect: adverse; 6 MET dropouts for medication side effects vs 0 PBO

Metformin caused significantly more diarrhea and headaches compared to placebo, with 6 dropouts in the metformin arm due to medication side effects versus none in placebo, though metformin users had f

Effect: adverse; 6 MET dropouts for medication side effects vs 0 PBO